Sex-Specific Effect of Estrogen Sulfotransferase on Mouse Models of Type 2 Diabetes
Open Access
- 14 May 2012
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 61 (6), 1543-1551
- https://doi.org/10.2337/db11-1152
Abstract
Estrogen sulfotransferase (EST), the enzyme responsible for the sulfonation and inactivation of estrogens, plays an important role in estrogen homeostasis. In this study, we showed that induction of hepatic Est is a common feature of type 2 diabetes. Loss of Est in female mice improved metabolic function in ob/ob, dexamethasone-, and high-fat diet–induced mouse models of type 2 diabetes. The metabolic benefit of Est ablation included improved body composition, increased energy expenditure and insulin sensitivity, and decreased hepatic gluconeogenesis and lipogenesis. This metabolic benefit appeared to have resulted from decreased estrogen deprivation and increased estrogenic activity in the liver, whereas such benefit was abolished in ovariectomized mice. Interestingly, the effect of Est was sex-specific, as Est ablation in ob/ob males exacerbated the diabetic phenotype, which was accounted for by the decreased islet β-cell mass and failure of glucose-stimulated insulin secretion in vivo. The loss of β-cell mass in ob/ob males deficient in Est was associated with increased macrophage infiltration and inflammation in white adipose tissue. Our results revealed an essential role of EST in energy metabolism and the pathogenesis of type 2 diabetes. Inhibition of EST, at least in females, may represent a novel approach to manage type 2 diabetes.Keywords
This publication has 43 references indexed in Scilit:
- Myeloid-specific estrogen receptor α deficiency impairs metabolic homeostasis and accelerates atherosclerotic lesion developmentProceedings of the National Academy of Sciences of the United States of America, 2011
- Estrogen Sulfotransferase Inhibits Adipocyte DifferentiationMolecular Endocrinology, 2011
- Estrogen and androgen receptors: regulators of fuel homeostasis and emerging targets for diabetes and obesityTrends in Endocrinology & Metabolism, 2011
- Estrogen sulfotransferase regulates body fat and glucose homeostasis in female miceAmerican Journal of Physiology-Endocrinology and Metabolism, 2010
- Impaired oxidative metabolism and inflammation are associated with insulin resistance in ERα-deficient miceAmerican Journal of Physiology-Endocrinology and Metabolism, 2010
- Minireview: Estrogenic Protection of β-Cell Failure in Metabolic DiseasesEndocrinology, 2009
- The Constitutive Androstane Receptor Is an Anti-obesity Nuclear Receptor That Improves Insulin SensitivityPublished by Elsevier BV ,2009
- The Role of Liver-Derived Insulin-Like Growth Factor-IEndocrine Reviews, 2009
- Gender-Specific Expression and Mechanism of Regulation of Estrogen Sulfotransferase in Adipose Tissues of the MouseEndocrinology, 2008
- Silencing of estrogen receptor α in the ventromedial nucleus of hypothalamus leads to metabolic syndromeProceedings of the National Academy of Sciences of the United States of America, 2007